Skip to content
Sunday, November 8, 2026
Daily Prime Media UK delivers breaking news, in-depth tech …

The Zimbabwean Government Turns Down ‘Lopsided’ US Health Aid Package Due to Information Concerns

Health aid image
The offered American funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

Zimbabwe has rejected a major American healthcare agreement worth 367 million US dollars (£272m) spanning five years because of Washington's request for confidential information.

This move was revealed following a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "lopsided".

An official spokesperson has since clarified that the US was requesting genetic material for scientific study and commercial gain but refused to share the resulting advantages from future medical innovations.

"We must now begin the difficult and regrettable task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the US had provided over $1.9bn in health funding to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for more talks to secure a agreement suitable to both sides so the nation's critical HIV programme can continue.

Wider Background

This rejection comes after a similar case in neighbouring Kenya, where a court suspended a similar health funding agreement following concerns were raised about the security of citizens' health data.

After resuming the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

The agency had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance openness and accountability.

As per statements, 16 African countries have to date signed similar agreements, constituting more than $18.3bn of fresh investment.

Specifics of the Declined Deal

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".

"It is our view this partnership might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," Tremont added.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"Our nation was requested to share its biological resources and data for a long time, with no equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.

"Put simply, our country would supply the basic resources for medical research without any assurance that the resulting innovations would be accessible to our citizens if a future disease outbreak arise."

National Interest and Global Health

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks already set up via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.

"This framework is designed to ensure that when a nation contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to develop them."

The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage ongoing discussions with our US partners on how future co-operation could be structured in a way that respects the sovereignty and dignity of each country."

Health Experts Reaction

A leading public health body expressed it understood the government's concerns, but suggested that talks need to persist considering much of the nation's HIV programmes depended on external financing.

"If technical issues arise, including those relating to information security or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.

This impasse emphasises the complex tensions between accepting much-needed international aid and safeguarding national sovereignty in an ever more data-driven world.

The writer

Juan Rodriguez

Elena Vance is a seasoned journalist and tech enthusiast, known for her insightful analysis and engaging storytelling across various media platforms.

Daily Prime Media UK

Type to search articles.